WuXi Healthcare Ventures

Total investments

40

Average round size

40M

Portfolio companies

26

Rounds per year

3.08

Lead investments

3

Follow on index

0.35

Exits

8

Stages of investment
Early Stage Venture
Areas of investment
Surgical DevicesDiagnostic EquipmentBiotechnologyHealth CareGeneticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeutics

Summary

The main department of described VC is located in the Cambridge. The fund was located in North America if to be more exact in United States.

The important activity for fund was in 2016. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year. Opposing the other organizations, this WuXi Healthcare Ventures works on 15 percentage points less the average amount of lead investments. The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. When the investment is from WuXi Healthcare Ventures the average startup value is 500 millions - 1 billion dollars. The increased amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars.

The overall number of key employees were 2.

The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Medical, Genetics. Among the most popular portfolio startups of the fund, we may highlight 23andMe, CStone Pharmaceuticals, Hua Medicine. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the WuXi Healthcare Ventures, startups are often financed by ARCH Venture Partners, Avalon Ventures, Torrey Pines Investment. The meaningful sponsors for the fund in investment in the same round are F-Prime Capital, ARCH Venture Partners, Canaan Partners. In the next rounds fund is usually obtained by Venrock, ARCH Venture Partners, 6 Dimensions Capital.

Show more

Investments analytics

Analytics

Total investments
40
Lead investments
3
Exits
8
Rounds per year
3.08
Follow on index
0.35
Investments by industry
  • Biotechnology (35)
  • Health Care (21)
  • Medical (15)
  • Therapeutics (14)
  • Pharmaceutical (13)
  • Show 16 more
Investments by region
  • United States (26)
  • China (13)
  • Israel (1)
Peak activity year
2016
Number of Unicorns
2
Number of Decacorns
2
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
203M
Group Appearance index
0.97
Avg. company exit year
7

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Kollabo 21 Sep 2021 Human Resources, Recruiting, SaaS, Marketing, Service Industry, Staffing Agency Seed 2M Zürich, Switzerland, Zurich
Siku Lifang 11 Mar 2021 Software, Enterprise, SaaS Early Stage Venture 15M Beijing, Dongcheng District, China
UNITY Biotechnology 19 Mar 2018 Biotechnology, Health Care, Medical Late Stage Venture 55M United States, California
Zenas BioPharma 23 Mar 2021 Health Care, Pharmaceutical, Biopharma Early Stage Venture

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.